(Q53201392)

English

Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.

scientific article published on 15 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

Fernando Cabanillas

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

11

object named as

L Fayad

0 references

Sattva S Neelapu

9

object named as

S S Neelapu

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

1

object named as

B Esmaeli

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

author name string

P McLaughlin

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

B Pro

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

F Samaniego

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

I Gayed

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

F Hagemeister

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

J Romaguera

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

R Banay

10

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

M Wayne Saville

12

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

L W Kwak

13

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

publication date

15 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

20

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

709-714

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

The epidemiology of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Malignant tumors of the orbit. Analysis of the Florida Cancer Registry.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Rapidly increasing incidence of ocular non-hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Ocular adnexal lymphoma: classification, clinical disease, and molecular biology

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Prevalence and nature of systemic involvement and stage at initial examination in patients with orbital and ocular adnexal lymphoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Curative radiotherapy for primary orbital lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Monoclonal antibodies: a new era in the treatment of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Current results and future applications of radioimmunotherapy management of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Yttrium 90 ibritumomab tiuxetan (Zevalin): a new bullet in the fight against malignant lymphoma?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Docetaxel secretion in tears: association with lacrimal drainage obstruction

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Monoclonal antibody treatment of orbital lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Ophthalmic and adnexal complications of radiotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Rituximab in primary conjunctiva lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN692

21 January 2018

Identifiers

10.1093/ANNONC/MDN692

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/19150940

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53201392&oldid=1753044409"